Viewing nowYoungil Clopidogrel Tablet (Clopidogrel Sulfate)
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

MFDS item code 200501925 · Notified 2005.10.26 · Insurance code 649402010
Improvement of acute coronary syndrome and symptoms of atherosclerosis; prevention of blood clots in atrial fibrillation
This medication is used to improve atherosclerotic symptoms in adults with ischemic stroke, myocardial infarction, and peripheral arterial disease. It also helps reduce the risk of cardiovascular complications in patients with acute coronary syndrome who have unstable angina or non-Q-wave myocardial infarction and have received drug therapy, coronary intervention, or coronary artery bypass surgery. Finally, it reduces the risk of stroke and thromboembolism in patients with atrial fibrillation who have vascular risk factors and for whom vitamin K antagonists are not suitable. This medication is effectively used for the treatment of cardiovascular diseases and the prevention of complications.
Adults 1. Patients with ischemic stroke, myocardial infarction, or peripheral arterial disease: Administer clopidogrel 75 mg orally once daily. 2. Patients with acute coronary syndrome (unstable angina or non-Q-wave myocardial infarction): On the first day of treatment, initiate this medicine with a loading dose of 300 mg once daily, followed by a maintenance dose of 75 mg orally once daily. Aspirin 75 ~ 325 mg should be coadministered with this medicine once daily. 3. Patients with atrial fibrillation: Administer 75 mg of this medicine orally once daily. Aspirin 75 ~ 100 mg should be coadministered with this medicine once daily. Patients with renal impairment : Treatment experience in patients with renal impairment is limited. Patients with hepatic impairment : Treatment experience in patients with moderate liver disease and bleeding diathesis is limited. This medicine may be administered with or without food.
This medication works by inhibiting platelet aggregation to prevent blood clotting. Individuals with genetically reduced function of a specific enzyme (CYP2C19) may experience reduced effectiveness of this medication, and in such cases, treatment strategies should be reconsidered. Coadministration of this medication with drugs that activate CYP2C19 can increase the concentration of this medication and raise the risk of bleeding, hence coadministration is not recommended. Individuals who are allergic to this medication or its components, those with bleeding disorders, patients with severe liver damage, and nursing mothers should not take this medication. Additionally, those with genetic diseases that prevent the digestion of lactose or allergies to soybean oil, beans, or peanuts should avoid this medication. Patients at high risk of bleeding or suspected of having bleeding symptoms should inform their doctors immediately, and if surgery is planned, it is advisable to discontinue this medication 5 to 7 days prior to the procedure. Coadministration with other antiplatelet agents, anticoagulants, nonsteroidal anti-inflammatory drugs (NSAIDs), selective serotonin reuptake inhibitors (SSRIs), etc., may increase the risk of bleeding, thus caution is necessary. For pregnant women, although there is not significant impact on the fetus, the risk of bleeding during childbirth may increase, so discontinuing this medication 5 to 7 days before delivery is recommended. For nursing mothers, it is uncertain whether this medication is excreted in breast milk, and they should consult their doctor regarding discontinuation of breastfeeding or this medication. Safety in children has not been established, thus it is advisable not to administer it to pediatric patients. Elderly individuals or patients with impaired kidney and liver function may have an increased risk of bleeding, requiring dosage adjustment and careful monitoring. Overdosage may lead to severe bleeding and there is no antidote to reverse the effects of this medication; platelet transfusion may be required in case of severe bleeding. This medication should be stored out of reach of children, and it is safer not to transfer it to another container. If any adverse symptoms such as bleeding, skin rash, difficulty breathing, severe abdominal pain, or persistent headache occur during use, immediate medical attention is required.
Hemorrhage, purpura, contusion, hematoma, epistaxis, hematuria, intraocular hemorrhage, intracranial hemorrhage, neutropenia, agranulocytosis, aplastic anemia, thrombocytopenia, abdominal pain, dyspepsia, diarrhea, nausea, rash, pruritus, chest pain, accidental injury, influenza-like illness, pain, fatigue, edema, hypertension, headache, dizziness, vomiting, depression, upper respiratory tract infection, dyspnea, rhinitis, bronchitis, cough, urinary tract infection, syncope, palpitations, asthenia, fever, hernia, heart failure, atrial fibrillation, leg cramps, sensory impairment, neuralgia, paresthesia, vertigo, constipation, elevated liver enzymes, gout, hyperuricemia, arthritis, arthrosis, anxiety, insomnia, anemia, pneumonia, sinusitis, eczema, skin ulcer, cystitis, cataract, conjunctivitis, herpes zoster, erythematous rash, papular urticaria, urticaria, renal dysfunction, acute renal failure, gynecomastia, elevated prostate-specific antigen, hypochromic anemia, leukemia, leukopenia, eosinophilia, confusion, hallucinations, taste disturbance, ageusia, vasculitis, hypotension, bronchospasm, interstitial pneumonia, eosinophilic pneumonia, colitis, pancreatitis, gastritis, stomatitis, hepatitis, acute liver failure, papular urticaria, urticaria, itching, angioedema, vesicular dermatitis, drug-induced hypersensitivity syndrome, drug rash with eosinophilia and systemic symptoms, lichen planus, myalgia, glomerulopathy, fever, abnormal liver function tests, increased blood creatinine, cholecystitis, hematemesis, spinal hematoma
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture, thus it should be stored in a tightly sealed container. Additionally, it is recommended to store the medication at room temperature between 1 degree to 30 degrees Celsius. This will help maintain the medication's efficacy.
Pink round film-coated tablet
Bottle packaging - 30 tablets/bottle, Bottle packaging - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowClopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Youngil Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Geonil Pharmaceutical Co., Ltd.
Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Sama Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Il Yang Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Korea Union Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
(Co., Ltd.) Korea Pharma

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Clopidogrel Bisulfate 97.875mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.